https://onconnection.com.br/noticias/ 2021-03-29T20:35:30+00:00 https://onconnection.com.br/noticias/anvisa-aprova-imunoterapia-com-durvalumabe/ 2021-02-16T19:29:25+00:00 https://onconnection.com.br/wp-content/uploads/2021/01/ANVISA_durvalumabe.jpg https://onconnection.com.br/noticias/asco-lanca-diretriz-de-tratamento-adjuvante-para-o-cancer-de-mama/ 2021-02-16T20:14:07+00:00 https://onconnection.com.br/wp-content/uploads/2021/02/ASCO_mama_adjuvante.png https://onconnection.com.br/noticias/aprovacao-anvisa-aprova-a-combinacao-de-atezolizumabe-e-bevacizumabe-para-carcinoma-hepatocelular-avancado-imbrave-150/ 2021-02-16T20:14:20+00:00 https://onconnection.com.br/wp-content/uploads/2021/02/Atezo-LiverCancer.jpg https://onconnection.com.br/noticias/citorreducao-secundaria-otima-aumenta-a-sobrevida-de-pacientes-com-cancer-de-ovario-recorrente-sensivel-a-platina/ 2021-02-16T20:16:29+00:00 https://onconnection.com.br/wp-content/uploads/2021/02/CancerOvario-1.jpg https://onconnection.com.br/noticias/analise-final-de-sobrevida-livre-de-progressao-confirma-ganho-significativo-do-alectinibe-no-cpnpc-alk/ 2021-02-16T20:20:43+00:00 https://onconnection.com.br/wp-content/uploads/2021/02/Cancer-de-pulmao-quadrada.jpg https://onconnection.com.br/noticias/implicacoes-da-carga-de-mutacao-tumoral-na-indicacao-de-imunoterapia/ 2021-02-16T20:24:58+00:00 https://onconnection.com.br/wp-content/uploads/2021/02/TMB_IO-blog.jpg https://onconnection.com.br/noticias/estro-2020-radioterapia-hipofracionada-em-1-semana-pode-ser-uma-nova-estrategia-de-tratamento-adjuvante-no-cancer-de-mama/ 2021-03-11T19:17:43+00:00 https://onconnection.com.br/wp-content/uploads/2021/02/maquina-quadrada.jpg https://onconnection.com.br/noticias/psma/ 2021-03-22T21:11:47+00:00 https://onconnection.com.br/wp-content/uploads/2021/03/1_PSMA_PET-min.png https://onconnection.com.br/wp-content/uploads/2021/03/1_PET_mulher-min.jpg https://onconnection.com.br/noticias/impacto-dos-inibidores-de-met-no-cancer-de-pulmao-mais-uma-historia-de-sucesso-a-caminho/ 2021-03-22T21:15:46+00:00 https://onconnection.com.br/wp-content/uploads/2021/03/2_Pulmao_MET-min.jpg https://onconnection.com.br/noticias/aprovacao-anvisa-aprova-imunoterapia-com-avelumabe-no-tratamento-do-cancer-avancado-de-bexiga/ 2021-03-22T21:26:05+00:00 https://onconnection.com.br/wp-content/uploads/2021/03/3_Foto-ANVISA-para-cancer-de-bexiga-min.jpg https://onconnection.com.br/noticias/combinacao-de-antiangiogenico-com-osimertinibe-em-pacientes-com-mutacao-de-resistencia-t790m-do-egfr/ 2021-03-22T21:33:42+00:00 https://onconnection.com.br/wp-content/uploads/2021/03/4_Foto-para-cancer-de-pulmao.jpg https://onconnection.com.br/noticias/metodos-nao-invasivos-para-diagnostico-de-hepatocarcinoma/ 2021-03-22T21:35:27+00:00 https://onconnection.com.br/wp-content/uploads/2021/03/HCC-Biopsia1_marco21.jpg https://onconnection.com.br/noticias/imunoterapia-aumenta-chances-de-sobrevida-no-mesotelioma-maligno/ 2021-03-22T21:37:47+00:00 https://onconnection.com.br/wp-content/uploads/2021/03/Mesotelioma.jpg https://onconnection.com.br/noticias/mulheres-na-pos-menopausa-com-cancer-de-mama-e-axila-comprometida-podem-ser-poupadas-da-quimioterapia/ 2021-03-22T21:39:30+00:00 https://onconnection.com.br/wp-content/uploads/2021/03/RxponderMarco21.jpg https://onconnection.com.br/noticias/analise-final-de-sobrevida-global-consolida-apalutamida-como-opcao-de-tratamento-em-pacientes-com-cpsc-metastaticos/ 2021-03-29T17:21:37+00:00 https://onconnection.com.br/wp-content/uploads/2021/03/cancer-prostata.jpg https://onconnection.com.br/noticias/abemaciclibe-adjuvante-aumenta-a-sobrevida-livre-de-doenca-em-pacientes-com-cancer-de-mama-inicial-re-her2-de-alto-risco/ 2021-03-29T20:35:30+00:00 https://onconnection.com.br/wp-content/uploads/2021/03/cancer-de-mama.jpg